Preclinical studies and future directions in the development of new hematologic growth factors
β Scribed by Steven Gillis
- Publisher
- Springer US
- Year
- 1991
- Tongue
- English
- Weight
- 486 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Gemcitabine has been reported to be an active agent in pancreatic cancer. Recent applications have included the use of a fixed-dose rate regimen in patients with advanced pancreatic cancer based on the observation that deoxycytidine kinase is saturated at the plasma gemcitabine concentrations achiev
There have been considerable advances in neurobiology in recent years that are providing new directions for the development of novel classes of antidepressants. For example, the finding that corticotropin-releasing factor (CRF) is hypersecreted in depressed patients and mediates certain symptoms of
The directions of technological innovation and possible future development of the manufacturing technologies are examined, taking into consideration the environments surrounding the manufacturing technologies. The subjects for development in future manufacturing technologies are discussed, and in pa
## Abstract __cβSrc__ was the first protooncogene described and was among the first molecules in which tyrosine kinase activity was documented. cβSrc has been defined as a common modular structure that participates in much of the crosstalk between the cytoplasmic protein tyrosine kinases and tyrosi